Follow
Oscar M Rueda
Oscar M Rueda
MRC Investigator, Programme Leader, MRC-Biostatistics Unit. University of Cambridge
Verified email at mrc-bsu.cam.ac.uk - Homepage
Title
Cited by
Cited by
Year
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
58492012
Analysis of circulating tumor DNA to monitor metastatic breast cancer
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
24162013
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
22552012
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 11479, 2016
15172016
Progesterone receptor modulates ERα action in breast cancer
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
7222015
Interrogating open issues in cancer precision medicine with patient-derived xenografts
AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...
Nature Reviews Cancer 17 (4), 254-268, 2017
6372017
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 8760, 2015
5022015
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
4592012
A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds
A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ...
Cell 167 (1), 260-274. e22, 2016
4352016
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
3902013
A new genome‐driven integrated classification of breast cancer and its implications
SJ Dawson, OM Rueda, S Aparicio, C Caldas
The EMBO journal 32 (5), 617-628, 2013
3842013
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ...
Annals of Oncology 29 (5), 1203-1210, 2018
3252018
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
L Silwal-Pandit, HKM Vollan, SF Chin, OM Rueda, S McKinney, T Osako, ...
Clinical Cancer Research 20 (13), 3569-3580, 2014
3072014
Copynumber: efficient algorithms for single-and multi-track copy number segmentation
G Nilsen, K Liestøl, P Van Loo, HK Moen Vollan, MB Eide, OM Rueda, ...
BMC genomics 13 (1), 1-16, 2012
2932012
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ...
Nature 567 (7748), 399-404, 2019
2852019
Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems
S Alon, DR Goodwin, A Sinha, AT Wassie, F Chen, ER Daugharthy, ...
Science 371 (6528), eaax2656, 2021
2522021
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ...
Genome biology 15, 1-14, 2014
2352014
Multi-omic machine learning predictor of breast cancer therapy response
SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, HA Bardwell, ...
Nature 601 (7894), 623-629, 2022
2222022
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
HR Ali, HW Jackson, VRT Zanotelli, E Danenberg, JR Fischer, H Bardwell, ...
Nature Cancer 1 (2), 163-175, 2020
2132020
Master regulators of FGFR2 signalling and breast cancer risk
MNC Fletcher, MAA Castro, X Wang, I De Santiago, M O’Reilly, SF Chin, ...
Nature communications 4 (1), 2464, 2013
2032013
The system can't perform the operation now. Try again later.
Articles 1–20